Navigation Links
Inclinix-PMG Holdings, Inc. Announces Executive Management Changes
Date:7/11/2012

WILMINGTON, N.C. & WINSTON-SALEM, N.C., July 11, 2012 /PRNewswire/ -- Inclinix-PMG Holdings, a global clinical trial site and patient recruitment organization, today announced changes to the executive management team.

Dr. John Rubino of Raleigh Medical Group (RMG) has been appointed Medical Director of Inclinix-PMG Holdings, Inc. and also will serve as the head of the Principal Investigator Advisory Board. Dr. Rubino has been actively involved in clinical research for the past 22 years, and has been a Principal Investigator in over 600 trials. He was instrumental in developing clinical research in association with RMG and will lend his experience and expertise in clinical research to the Inclinix-PMG Holdings organization. Dr. Rubino says, "I look forward to helping meld the strengths of both Inclinix and PMG into the premier research organization by focusing on making our research efforts a win for patients, physicians and our research sponsors."

Jennifer Byrne has been named President and Chief Operating Officer of PMG Research Inc. Ms. Byrne has 25 years experience in the clinical research field. Through her various management roles, she has been influential in guiding the development and growth of PMG Research for the past 20 years, and will continue to do so in this capacity.

Denise Robinson has been named President and Chief Operating Officer of Inclinix, Inc. Ms. Robinson has over 15 years of pharmaceutical, clinical and healthcare experience. She has served in multiple leadership roles with Inclinix in her 10-year tenure and her experience and insight will provide valuable strategic direction for Inclinix.

"Together Inclinix and PMG Research bring forth an unrivaled precedent for research site-based experience which will allow for better outcomes for pharmaceutical sponsors, physician investigators, and research participants," says Ms. Byrne. Denise Robinson explains, "This merger is the great outcome of years of successf
'/>"/>

SOURCE Inclinix-PMG Holdings, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Bacterin International Holdings, Inc. Schedules Fourth Quarter 2011 Financial Earnings Conference Call
2. Innophos Holdings, Inc. Reports First Quarter 2012 Results
3. China Pharma Holdings, Inc. to Report First Quarter of Fiscal Year 2012 Financial Results on May 15, 2012
4. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
5. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations
6. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
7. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
8. GeoVax Labs, Inc. Announces Nine Month 2011 Financial Results
9. WuXi PharmaTech Announces Third-Quarter 2011 Results
10. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
11. Spherix Announces Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... May 24, 2013 Senomyx , Inc. ... taste science technologies to discover, develop, and commercialize novel ... , Ph.D., the Company,s Vice President, Biology and ... Relations & Corporate Communications, will present an overview of ... 10:25 a.m. Eastern Time (7:25 a.m. Pacific Time) during ...
(Date:5/24/2013)... Vestiage, Inc. (stock symbol "VEST") a publicly traded ... development, sales and marketing of premium branded highly ... it is awarding exclusive Vestiage territories in the ... Illuminating Facial Care. Qualified applicants can request an ... to info(at)vestiageinc(dot)com and putting RELUMA in the "Subject" ...
(Date:5/23/2013)... ROCK, Colo. , May 23, 2013 ... diagnostic company focused on obtaining FDA clearance and ... , today announced the pricing of an underwritten public ... related warrants to purchase 3,500,000 shares of its common ... at a combined public offering price of $1.25 per ...
(Date:5/23/2013)... 2013 Patheon Inc ., a ... the global pharmaceutical industry, will host a complimentary webinar ... Testing” on Tuesday, June 4, 2013 at 11 a.m. ... required to comply with regulations for cleaning validation. ... scientific underpinning and little evaluation of risk. Some ...
Breaking Biology Technology:SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CITI 2013 GLOBAL CONSUMER CONFERENCE 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 3Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 4Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 5Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3Patheon to Present on “Cleaning Validation: Science, Risk and Novel Approaches to Testing” 2
... YORK, Feb. 24, 2011 Reportlinker.com announces that ... its catalogue: Propylene Oxide: 2010 ... http://www.reportlinker.com/p0152026/Propylene-Oxide-2010-World-Market-Outlook-And-Forecast.html The report analyzes ... North America and Latin America. It provides the ...
... 24, 2011 Reportlinker.com announces that a new ... Global Marine Biotechnology Industry ... This report analyzes the Global markets for ... product segments- Marine Biomaterials, Marine Bioactive Substances, and ...
... Feb. 24, 2011 Palatin Technologies, Inc. (NYSE Amex: ... public offering of 23,000,000 units, consisting of 23,000,000 shares of ... of its common stock and Series B Warrants to purchase ... the public of $1.00 per unit. Palatin expects that the ...
Cached Biology Technology:Reportlinker Adds Propylene Oxide: 2010 World Market Outlook and Forecast 2Reportlinker Adds Global Marine Biotechnology Industry 2Palatin Technologies, Inc. Announces Pricing of Public Offering of Common Stock and Warrants 2Palatin Technologies, Inc. Announces Pricing of Public Offering of Common Stock and Warrants 3
(Date:5/22/2013)... must join together in a major new effort to ... in providing Earth,s people with clean water that looms ... a comment article in the current edition of ... the American Chemical Society (ACS), the world,s largest scientific ... Ph.D., and Jerald L. Schnoor, Ph.D., explain that shortages ...
(Date:5/22/2013)... DNA can endanger the whole organism, as they may ... (LMU) in Munich now report how byproducts of respiration ... The DNA in our cells controls the form and ... instructions for this are encoded in the linear sequence ... adenine (A), cytosine (C), guanine (G) and thymine (T). ...
(Date:5/22/2013)... the biodiversity of pollinating insects and wild plants have ... , Researchers led by the University of Leeds and ... evidence of dramatic reductions in the diversity of species ... and 1980s. , But the picture brightened markedly after ... losses among bees, hoverflies and wild plants. ...
Breaking Biology News(10 mins):DNA damage: The dark side of respiration 2Encouraging signs for bee biodiversity 2Encouraging signs for bee biodiversity 3
... Survey is the first poll to reflect the discovery ... be used to create stem cells or their near ... more than six in 10, or 63 percent, say ... still needed, 22 percent say this development means embryonic ...
... ... Solutions, GAITHERSBURG, ... and offerings in biometrics,solutions through a cooperation agreement with Cognitec Systems, ... between the two companies in the rapidly growing marketplace,for biometrics solutions., ...
... HOUSTON (Dec. 18, 2007)Researchers at The University of ... between genes regulating glucose metabolism and spina bifida. The ... from parents and their children with that birth defect. ... dozen genes that take part in glucose metabolism to ...
Cached Biology News:Widespread support for nonembryonic stem cell research, VCU Life Sciences Survey shows 2Lockheed Martin Advances Biometrics Portfolio Through Cooperation Agreement With Cognitec 2UT-Houston's Northrup and colleagues uncover genetic link to spina bifida 2
... Phosphatase-2A (PPase-2A) is a serine/threonine phosphatase isolated ... isolated as the heterodimer of 60kDa (A) ... ability to dephosphorylate the a-subunit of phosphorylase ... has broad substrate specificity and may play ...
Immulon 2 HB 1x8 Strip assembled, C-bottom; high binding irradiated surface to provide increased binding affinity for hydrophilic proteins and complexes....
... The RVT405DDA Refrigerated Vapor Trap is ... high boiling solvents such as DMSO ... systems. Its constant temperature refrigeration system ... optimum cryopumping conditions for DMSO, while ...
96 Well Plate EB, RE bottom; high binding irradiated surface to provide increased binding affinity for hydrophilic proteins and complexes. Guaranteed coefficient of variation (CVs)....
Biology Products: